# Woolsey Pharmaceuticals, Inc. — Form D

Woolsey Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-15. $19.7M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2021-10-15
- Form: D
- Accession: 0001804846-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $19.7M
- Investors: 41
- Date of first sale: 2021-07-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-417089

## Issuer

- Name: Woolsey Pharmaceuticals, Inc.
- CIK: 0001804846
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 233 BROADWAY, SUITE 1750, NEW YORK, NY, 10279
- Phone: 212-586-2226

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| DAVID M GELIEBTER | Director | NEW YORK, NY |
| SVEN M JACOBSON | Director | NEW YORK, NY |
| DAVID M GELIEBTER | Executive Officer | NEW YORK, NY |
| SVEN M JACOBSON | Executive Officer | NEW YORK, NY |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2020-04-08](https://search.stillhousedata.com/formd/0001804846-20-000002) | D/A | — | $8.6M |
| [2020-03-04](https://search.stillhousedata.com/formd/0001804846-20-000001) | D | $7.8M | $7.8M |

## More

- [CIK 1804846 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1804846&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001804846-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.